Reagan-Udall Annual Meeting: 4 Takeaways From US FDA Center Directors

US Food and Drug Administration wonks flocked to the Reagan-Udall annual meeting on 2 May to see new acting commissioner Norman Sharpless give one of his first public addresses. But the agency's center directors also convened to share some perspectives during a more than hour-long panel discussion. Below are some of the key takeaways from their remarks.

The FDA has long been worried about the slow pace of medical advances in the antimicrobial arena, and Center for Drug Evaluation and Research (CDER) director Janet Woodcock fears it